Category Pharmaceuticals and Biotech

Biohacking: Industry Disruptor, Social Movement Gaining Ground
Press Release -

Biohacking: Industry Disruptor, Social Movement Gaining Ground

Changes Expected in Healthcare, Tech, Wellness, and Beauty Industries Within 5 years

CaryRx Aims to Uberize Pharmacies With the Launch of Their Mobile First Enterprise Pharmacy Platform
Press Release -

CaryRx Aims to Uberize Pharmacies With the Launch of Their Mobile First Enterprise Pharmacy Platform

Enabling any pharmacy to modernize with a feature-rich HIPAA compliant cloud-based pharmacy platform

Lotus Clinical Research Announces the Addition of Robert Dworkin, PhD as Director, Chronic Pain Research
Press Release -

Lotus Clinical Research Announces the Addition of Robert Dworkin, PhD as Director, Chronic Pain Research

Robert Dworkin, Ph.D. Joins Lotus Clinical Research as Director, Chronic Pain Research to lead Lotus' chronic pain research programs

KARMET Study Begins Enrollment
Press Release -

KARMET Study Begins Enrollment

Helping Patients Set Healthy Goals for the New Year
Press Release -

Helping Patients Set Healthy Goals for the New Year

VMS BioMarketing Clinical Educator Teresita Buenrostro shares how to help patients improve self-management of chronic illnesses

Launch of Dermatology GPO DermSource a Success
Press Release -

Launch of Dermatology GPO DermSource a Success

Looking for Strength in Numbers

Press Release -

Growing Skin in the Lab for the Treatment of Advanced Wounds

IDTechEx Research outlines the use of living therapies in the care of advanced wounds

Cutting Through the Industry 4.0 Paradigm: It's Not About Big Data, but How to Use Your Data, New Webinar Hosted by Xtalks
Press Release -

Cutting Through the Industry 4.0 Paradigm: It's Not About Big Data, but How to Use Your Data, New Webinar Hosted by Xtalks

The life science industry has always been steps ahead when it comes to data collection and analysis. It's possible to argue it has been embracing 'Industry 4.0' methodology before the term existed. However, companies have also been aware of the pitfalls of 'big data' for over 40 years.

First Light Biosciences Develops Rapid Test for C. Difficile Toxin B. in Stool Samples
Press Release -

First Light Biosciences Develops Rapid Test for C. Difficile Toxin B. in Stool Samples

Results of Technical Study Presented at ASM Microbe 2018

Recent Technological Advancements in Medical Communication, New Webinar Hosted by Xtalks
Press Release -

Recent Technological Advancements in Medical Communication, New Webinar Hosted by Xtalks

Join this webinar for a discussion of the most common medical communications business challenges and potential solutions. This event will also feature a live demonstration of how patient-centric medical communications technology can be leveraged to streamline and optimize medical inquiry fulfillment, adverse event reporting and product complaint management.

First Light Biosciences Announces Funding From Biomedical Advanced Research and Development Authority (BARDA)
Press Release -

First Light Biosciences Announces Funding From Biomedical Advanced Research and Development Authority (BARDA)

A contract extension representing $10.7 million over two years

Purchase Power is Back in the Hands of Independent Pharmacies
Press Release -

Purchase Power is Back in the Hands of Independent Pharmacies

Members Standing Together in Fighting Price Hikes

Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bringing Decades of Research and Experience
Press Release -

Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bringing Decades of Research and Experience

​​Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member.

Latest Biologic Launch in Psoriasis, UCB's Cimzia, Having a Tough Time Getting Traction, But Developing a Presence in Dermatology May Lay Foundation for Bimekizumab in the Future
Press Release -

Latest Biologic Launch in Psoriasis, UCB's Cimzia, Having a Tough Time Getting Traction, But Developing a Presence in Dermatology May Lay Foundation for Bimekizumab in the Future

Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights

Primate Research Firm Explores Blockchain Technology
Press Release -

Primate Research Firm Explores Blockchain Technology

Alpha Genesis initiative with important medical research implications

Masy BioServices to Distribute New Products
Press Release -

Masy BioServices to Distribute New Products

Masy, a leading provider of quality solutions for Life Sciences, is now offering precision products from SenseAnywhere and Insatech